The fallacy of enrolling only high-risk subjects in cancer prevention trials: Is there a "free lunch"?
-
* Corresponding author: Stuart G Baker sb16i@nih.gov
BMC Medical Research Methodology 2004, 4:24 doi:10.1186/1471-2288-4-24
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 16 Mar 2004 | |
| Reviewer's Report | Richard Kryscio | 22 Jun 2004 | |
| Reviewer's Report | Melissa Clark | 22 Jul 2004 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 11 Aug 2004 |
| Resubmission - Version 3 | Manuscript | Author's comment | 11 Aug 2004 |
| Reviewer's Report | Melissa Clark | 26 Aug 2004 | |
| Reviewer's Report | Richard Kryscio | 27 Aug 2004 | |
| Editor's comment | Editor's comment | 14 Sep 2004 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 01 Oct 2004 |
| Published | 04 Oct 2004 |